Cancer Type: DT/Phase 1

For more information about any of the clinical trials listed on this site, call 314-747-7222 or 800-600-3606 toll free or email Patient_Care_Coordination_Center@bjc.org.

Select Basic Search to view clinical trials grouped by category and Advanced Search to be able to further narrow search results.

 

201407100

A PHASE 1B CLINICAL TRIAL TO EVALUATE THE SAFETY AND IMMUNE RESPONSE TO A MAMMAGLOBIN-A DNA VACCINE IN ER+, HER2- BREAST CANCER PATIENTS UNDERGOING NEOADJUVANT ENDOCRINE THERAPY OR CHEMOTHERAPY

201506113

A Phase 1 Clinical Trial to Evaluate the Safety and Immunogenicity of a Personalized Synthetic Long Peptide Breast Cancer Vaccine Strategy in Patients with Persistent Triple-Negative Breast Cancer Following Neoadjuvant Chemotherapy

201710109

A Randomized Phase 1 Trial of Neoantigen DNA Vaccine Alone vs. Neoantigen Vaccine Plus Durvalumab in Triple Negative Breast Cancer Patients Following Standard of Care Therapy

201405031

An Open-Label, Phase 2 Basket Study of Neratinib in Patients with Solid Tumors with Somatic Activating HER Mutations

201503012

A Phase 1/2, Open-Label, Dose Escalation, Safety, and Tolerability Study of INCB054828 in Subjects with Advanced Malignancies

201508140

A Phase I Study of Ipilimumab and Nivolumab in Advanced HIV associated Solid Tumors with Expansion Cohorts in HIV Associated Solid Tumors and a Cohort of HIV-Associated Classical Hodgkin Lymphoma

201509039

Molecular Analysis for Therapy Choice (MATCH)

201510016

A Phase II Study of sEphB4-HSA in Kaposi Sarcoma

201607078

A Pilot Study of Nelfinavir for the Treatment of Kaposi Sarcoma A Trial of the AIDS Malignancy Consortium (AMC)

201703028

Dual Anti-CTLA-4 and Anti-PD-1 blockade in Rare Tumors